What question did this study set out to answer?

The study aims to analyze treatment patterns and healthcare costs associated with multiple myeloma in Brazil using real-world data.

Treatment Patterns and Direct Costs of Multiple Myeloma in Brazil: A Retrospective Cohort Analysis Using Real‐World Data

View Full Paper

Ask AI

Bookmark

Authors

Retrospective cohort analysis describes treatment patterns and costs in multiple myeloma, highlighting significant findings.

The study aims to analyze treatment patterns and healthcare costs associated with multiple myeloma in Brazil using real-world data.
Retrospective analysis of administrative claims data from Unimed Paraná, Brazil, from 2014 to 2024.
Eligible patients had ≥ 9 claims linked to multiple myeloma specifics (ICD-10 C90.0).
Process mining performed using UpFlux AI, with statistical analyses in R and GraphPad Prism.
68 patients were included in the analysis, with a mean total treatment cost per patient of USD 186350.83 (SD = 164645.73).
Annual costs differed significantly between patients initiating therapy in 2014–2019 and those in 2020–2024 (USD 57083.10 vs. USD 97397.11; p = 0.011).
Costs increased significantly with treatment complexity from single-exposed (USD 3491.26) to triple-exposed therapies (USD 12796.55; p < 0.001).

RAMOS et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark